Aegle Therapeutics

Aegle Therapeutics Corp. is a leading biotechnology company that has isolated extracellular vesicles from allogeneic bone marrow-derived mesenchymal stem cells to treat severe skin conditions, including burns and epidermolysis bullosa. Aegle's EV therapy utilizes its proprietary platform isolation technology, which has the potential to demonstrate a safer and more cost-effective method of harnessing the regenerative healing power of stem cells. Aegle believes its therapy has the potential for functional regeneration and the structuring of complex tissue architectures, which could enhance healing, reduce scarring, minimize contractures, and improve overall cosmetic outcomes.